$Reviva Pharmaceuticals Holdings, Inc.(RVPH)$ activity swept through select biotech and medical device names Thursday, with several micro- and mid-cap stocks posting sharp gains following session-end catalysts, volume spikes, or pipeline updates. Below are key price moves and developments from RVPH, PEN, PALI, IOBT, RLYB, and VOR.
Reviva Pharmaceuticals Holdings Inc. (RVPH) extended its explosive rally into after-hours trading Thursday, jumping 18.27% to $0.58 following a 35.1% surge during the regular session. The move came on a staggering volume of over 40.5 million shares, nearly nine times its daily average. RVPH traded between $0.3700 and $0.5338 intraday, and the stock remains well below its 52-week high of $4.28. Reviva Pharm Holdings Price Target Announced at $2.00/Share by Chardan Capital. What is price target $15 or $ 2?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
